JIP
IBB icon

Jaffetilchin Investment Partners’s iShares Biotechnology ETF IBB Stock Holding History

Jaffetilchin Investment Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,816
Closed -$232K – 448
2025
Q1 		$232K Buy
1,816
+1
+0.1% +$136 0.02% 369
2024
Q4 		$240K Buy
1,815
+1
+0.1% +$141 0.02% 346
2024
Q3 		$264K Buy
1,814
+17
+0.9% +$2.46K 0.02% 317
2024
Q2 		$247K Sell
1,797
-23
-1% -$3.07K 0.02% 302
2024
Q1 		$250K Buy
1,820
+4
+0.2% +$546 0.02% 314
2023
Q4 		$247K Sell
1,816
-1,355
-43% -$165K 0.02% 303
2023
Q3 		$388K Hold
3,171
– – 0.04% 235
2023
Q2 		$403K Sell
3,171
-10,922
-77% -$1.42M 0.04% 229
2023
Q1 		$1.82M Sell
14,093
-61
-0.4% -$7.99K 0.21% 87
2022
Q4 		$1.86M Buy
14,154
+6,035
+74% +$780K 0.23% 86
2022
Q3 		$950K Sell
8,119
-35
-0.4% -$4.35K 0.12% 109
2022
Q2 		$959K Buy
8,154
+1,130
+16% +$134K 0.11% 124
2022
Q1 		$769K Sell
7,024
-33,190
-83% -$4.32M 0.09% 144
2021
Q4 		$6.14M Buy
40,214
+711
+2% +$110K 0.58% 39
2021
Q3 		$6.39M Sell
39,503
-21,868
-36% -$3.68M 0.68% 32
2021
Q2 		$9.74M Buy
61,371
+30,408
+98% +$4.68M 0.67% 30
2021
Q1 		$4.66M Buy
30,963
+6,118
+25% +$972K 0.55% 40
2020
Q4 		$3.76M Buy
+24,845
New +$3.55M 0.53% 30
2019
Q2 		– Sell
-9,267
Closed -$1.04M – 296
2019
Q1 		$1.04M Hold
9,267
– – 0.23% 68
2018
Q4 		$894K Sell
9,267
-749
-7% -$79.5K 0.22% 62
2018
Q3 		$1.22M Buy
+10,016
New +$1.18M 0.26% 68
2017
Q2 		– Sell
-2,259
Closed -$221K – 256
2017
Q1 		$221K Buy
+2,259
New +$216K 0.06% 232

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Jaffetilchin Investment Partners's IBB Position: Q2 2025 in Review

Jaffetilchin Investment Partners sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 1,816 shares — an estimated $232K sold.

Jaffetilchin Investment Partners first reported a position in IBB in Q1 2017 and held it in 22 quarters. The position peaked at $9.74M in Q2 2021. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

  • Jaffetilchin Investment Partners reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 1,816 iShares Biotechnology ETF shares in Q2 2025, an estimated $232K.
  • Jaffetilchin Investment Partners first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 22 quarters.
  • Jaffetilchin Investment Partners's iShares Biotechnology ETF position peaked at $9.74M in Q2 2021.
  • 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on Jaffetilchin Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.